Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment

Autors/ores

  • Madiha Mehmood Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan
  • Muhammad Anees Department of Nephrology, King Edward Medical Universiy, Lahore, Pakistan

DOI:

https://doi.org/10.53778/pjkd92302

Paraules clau:

acute kidney injury, anti tuberculous treatment, ATT, Rifampicin, Isoniazid, AKI

Resum

Although life-saving, anti-tuberculosis therapy (ATT) carries the risk of acute kidney injury (AKI), potentially complicating its management.

 

Methods: 102 subjects starting on ATT were followed for 2 months. Presence of AKI was documented with monitoring of kidney functions.

Results:

AKI was observed among 14.7% patients, predominantly affecting middle-aged males.

Conclusion:

Early recognition of AKI by monitoring for kidney function is crucial for reducing the risk of long-term sequelae of kidney failure among patients taking ATT.

PJKD

Descàrregues

Publicat

2025-06-30

Número

Vol. 9 Núm. 2 (2025): Pakistan Journal of Kidney Diseases

Secció

Original Article

Llicència

Drets d'autor (c) 2025 Madiha Mehmood, Dr Muhammad Anees

Creative Commons License

Aquesta obra està sota una llicència internacional Creative Commons Reconeixement-NoComercial 4.0.

Com citar

Acute Kidney Injury in Patients Receiving Anti-Tuberculosis Treatment. (2025). Pakistan Journal of Kidney Diseases, 9(2), 16-19. https://doi.org/10.53778/pjkd92302